TheStreet Biotech (@TSTbiotech) header
TheStreet Biotech (@TSTbiotech) profile picture

News affecting the biotech industry and associated stocks. Includes #biotech trends, market analysis as well as mergers and acquisition news. cc: @TheStreet

New York, NY
Joined October 2011
Photo by TheStreet Biotech (@TSTbiotech)Photo by TheStreet Biotech (@TSTbiotech)Photo by TheStreet Biotech (@TSTbiotech)Photo by TheStreet Biotech (@TSTbiotech)Photo by TheStreet Biotech (@TSTbiotech)Photo by TheStreet Biotech (@TSTbiotech)Photo by TheStreet Biotech (@TSTbiotech)Photo by TheStreet Biotech (@TSTbiotech)Photo by TheStreet Biotech (@TSTbiotech)Photo by TheStreet Biotech (@TSTbiotech)
New home for @TheStreet's #biotech news. Includes trends, market analysis as well as mergers and acquisition news.
3
6
14
Celgene, Agios Expand, Amend Cancer Drug Partnership dlvr.it/LLSGFV
58
16
Heron and the never-ending FDA drug review dlvr.it/LLRmZR
1
42
12
Heron and the never-ending FDA drug review dlvr.it/LLNbYj
1
51
7
Celgene, Agios Expand, Amend Cancer Drug Partnership dlvr.it/LL17gk
50
9
Investors comforted as Perrigo sticks to forecast dlvr.it/LKx9q0
51
6
$REGN spike not tied to $PFE's $ANAC deal, but it doesn't hurt dlvr.it/LKYmNy
63
8
Pfizer beats Allergan to excema-drugmaker Anacor for $5.2B dlvr.it/LKTpTn
60
5
Aduro Biotech Pancreatic Cancer Immunotherapy Fails Mid-Stage Study dlvr.it/LKS1fy
54
8
Pfizer Buying Anacor in $5.2 Billion Cash Deal dlvr.it/LKNMtF
44
10
$MDVN shares stand pat amid further bid speculation dlvr.it/LJR9kW
50
9
$MYL tacks on another generics company on the cheap dlvr.it/LJKvns
40
7
Biotech Stock Mailbag: Why Intrexon CEO R.J. Kirk should not be trusted $XON dlvr.it/LJCHFD
New regime at $PRGO provides reason to invest dlvr.it/LHxJV8
56
10
Cramer says buy $DOW & $DD over $MON in seed business dlvr.it/LHtcG3
37
13
Mast (mstx) sickle cell drug seeks to defy long odds like leicester city dlvr.it/LHmxLP
51
10
DOJ investigation has little impact on pharmas' share prices dlvr.it/LHR5s7
Global bidding war seen for Medivation dlvr.it/LHPJB9
49
13
$AGN authorizes $10 billion buy back, beats estimates dlvr.it/LGslpr
52
6
CytRx bear thesis explained: why sarcoma drug trial will fail dlvr.it/LGs5kh
50
10